Gene Silencing Market to Grow with a CAGR of 7.48% through 2030
Surge in research and development activities is
expected to drive the Global Gene Silencing Market growth in the forecast
period, 2026-2030.
According to TechSci Research report, “Gene Silencing
Market - Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, the Global Gene Silencing Market stood at USD 2.86
Billion in 2024 and is anticipated to grow with a CAGR of 7.48% through 2030. Initiatives
taken by government based on gene silencing has led to favorable market
conditions for the Global Gene Silencing Market. Several factors contribute to
the growth of various gene silencing products.
The rapid advancements in genomics and molecular
biology have fueled a deeper understanding of gene functions and interactions,
providing the foundation for gene silencing research. The surge in R&D
activities has led to the identification of specific genes that contribute to
the progression of diseases, offering new therapeutic targets for gene
silencing techniques. This expansion of research is opening new avenues for
drug development, particularly for diseases previously considered untreatable,
thereby driving the growth of the gene silencing market.
Governments, especially in developed countries like the United States, the European Union, and Japan, have allocated substantial funding to support gene silencing research. For example, the U.S. National Institutes of Health (NIH) has provided significant grants to researchers working on RNA interference (RNAi) and antisense oligonucleotides (ASOs), focusing on their potential to treat genetic disorders, cancers, and viral infections. In the European Union, the Horizon Europe program provides funding for research and innovation in biotechnology, including gene silencing, encouraging collaborative projects across member states.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Gene Silencing Market”
The Global Gene Silencing Market is segmented into product
& service, application, regional distribution, and company.
Based on Product & Service, CRISPR-Cas9
have emerged as the dominating segment in the Global Gene Silencing Market in
2024. One of the main reasons for CRISPR-Cas9’s dominance is its remarkable
precision. Unlike other gene silencing methods, CRISPR-Cas9 can be programmed
to target almost any gene in the genome, enabling scientists to accurately
silence or modify the activity of specific genes. This precision has made it
the preferred choice for a wide range of applications, including functional
genomics, drug discovery, and therapeutic development, as it allows for the
precise manipulation of genetic material with minimal off-target effects. This
capability has fueled a surge in research and development activities using
CRISPR-Cas9 technology, driving the expansion of this market segment.
Based on Region, Asia Pacific have emerged as the fastest
growing region in the Global Gene Silencing Market in 2024. Many countries in
the Asia Pacific region, particularly China, Japan, South Korea, and India,
have made significant investments in biotechnology research and development.
This has led to the establishment of advanced research facilities, increased
funding for gene-based therapies, and a favorable environment for the growth of
the gene silencing market. These countries are becoming key hubs for
cutting-edge research in gene silencing technologies.
Major companies operating in Global Gene Silencing
Market are:
- Revvity, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- GenScript Biotech Corporation
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- New England Biolabs, Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“One of the significant advantages of nanotechnology
in gene silencing is its ability to improve the targeted delivery of
gene-silencing molecules such as RNA interference (RNAi) or antisense
oligonucleotides (ASOs). Nanoparticles, such as lipid-based nanoparticles
(LNPs) or polymer-based nanocarriers, have been developed to encapsulate these
therapeutic agents, protecting them from degradation in the bloodstream and
ensuring they reach the intended cells or tissues. This precision targeting
reduces the risk of off-target effects and enhances the overall therapeutic
efficacy, which is particularly valuable for treating genetic and rare diseases”,
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Gene Silencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (RNAi, CRISPR-Cas9, Antisense Oligonucleotides, Others), By Application (Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Others), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Gene Silencing Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Gene Silencing Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com